Infection Control

Strategies to prevent the spread of vancomycin-resistant enterococci in your facility

Briefings on Infection Control, June 1, 2008

This is an excerpt from a member only article. To read the article in its entirety, please login.

Vancomycin-resistant enterococci (VRE) spends far less time in the spotlight than MDROs, particularly MRSA. Although this organism may be less pathogenic than some of its more famous counterparts, it still poses a serious concern for healthcare facilities.

Not only does VRE cause complications for already sick patients, resulting in longer stays and higher costs, but there is another concern—chiefly that it will meet with MRSA in a co-colonized patient and mutate, spreading vancomycin-resistant Staphylococcus aureus (VRSA), says Connie Steed, RN, BSN, CIC, manager of IC at the Greenville (SC) Hospital System.

This is an excerpt from a member only article. To read the article in its entirety, please login.

Comments

0 comments on “Strategies to prevent the spread of vancomycin-resistant enterococci in your facility

 

    Patient Safety Monitor
  • Patient Safety Monitor

    As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...

  • Patient Safety Monitor Alert

    This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...

  • Infection Control Weekly Monitor

    Infection Control Weekly Monitor keeps you up-to-date on what's happening in the world of infection control. Every issue...

Most Popular

Related Articles